These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23007216)

  • 21. Melasma in Latin Americans.
    Perez M; Luke J; Rossi A
    J Drugs Dermatol; 2011 May; 10(5):517-23. PubMed ID: 21533299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Vascular Component of Melasma: A Systematic Review of Laboratory, Diagnostic, and Therapeutic Evidence.
    Masub N; Nguyen JK; Austin E; Jagdeo J
    Dermatol Surg; 2020 Dec; 46(12):1642-1650. PubMed ID: 33252894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.
    Rodríguez-Arámbula A; Torres-Álvarez B; Cortés-García D; Fuentes-Ahumada C; Castanedo-Cázares JP
    Am J Dermatopathol; 2015 Oct; 37(10):761-6. PubMed ID: 26381025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facial melanoses: Indian perspective.
    Khanna N; Rasool S
    Indian J Dermatol Venereol Leprol; 2011; 77(5):552-63; quiz 564. PubMed ID: 21860153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution.
    Kang HY; Bahadoran P; Suzuki I; Zugaj D; Khemis A; Passeron T; Andres P; Ortonne JP
    Exp Dermatol; 2010 Aug; 19(8):e228-33. PubMed ID: 20497220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What should be considered in treatment of melasma.
    Kang HY; Ortonne JP
    Ann Dermatol; 2010 Nov; 22(4):373-8. PubMed ID: 21165205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review.
    Piętowska Z; Nowicka D; Szepietowski JC
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial.
    Khemis A; Kaiafa A; Queille-Roussel C; Duteil L; Ortonne JP
    Br J Dermatol; 2007 May; 156(5):997-1004. PubMed ID: 17388924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melasma: histopathological characteristics in 56 Korean patients.
    Kang WH; Yoon KH; Lee ES; Kim J; Lee KB; Yim H; Sohn S; Im S
    Br J Dermatol; 2002 Feb; 146(2):228-37. PubMed ID: 11903232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mandibular melasma.
    Mandry Pagán R; Sánchez JL
    P R Health Sci J; 2000 Sep; 19(3):231-4. PubMed ID: 11076368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: a comparative study.
    Miot LD; Miot HA; Polettini J; Silva MG; Marques ME
    Am J Dermatopathol; 2010 Oct; 32(7):676-82. PubMed ID: 20534990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melasma: an Up-to-Date Comprehensive Review.
    Ogbechie-Godec OA; Elbuluk N
    Dermatol Ther (Heidelb); 2017 Sep; 7(3):305-318. PubMed ID: 28726212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Finasteride associated melasma in a Caucasian male.
    Famenini S; Gharavi NM; Beynet DP
    J Drugs Dermatol; 2014 Apr; 13(4):484-6. PubMed ID: 24719069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of melasma with Pycnogenol.
    Ni Z; Mu Y; Gulati O
    Phytother Res; 2002 Sep; 16(6):567-71. PubMed ID: 12237816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneous Pathology of Melasma and Its Clinical Implications.
    Kwon SH; Hwang YJ; Lee SK; Park KC
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular structure and concentration of melanin in the stratum corneum of patients with melasma.
    Moncada B; Sahagún-Sánchez LK; Torres-Alvarez B; Castanedo-Cázares JP; Martínez-Ramírez JD; González FJ
    Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):159-60. PubMed ID: 19438997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of melasma.
    Rendon M; Berneburg M; Arellano I; Picardo M
    J Am Acad Dermatol; 2006 May; 54(5 Suppl 2):S272-81. PubMed ID: 16631968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Melasma : An update on the clinical picture, treatment, and prevention].
    Becker S; Schiekofer C; Vogt T; Reichrath J
    Hautarzt; 2017 Feb; 68(2):120-126. PubMed ID: 28084498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiopathology of melasma].
    Miot LD; Miot HA; Silva MG; Marques ME
    An Bras Dermatol; 2009; 84(6):623-35. PubMed ID: 20191174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilizing combination therapy to optimize melasma outcomes.
    Rendon MI
    J Drugs Dermatol; 2004; 3(5 Suppl):S27-34. PubMed ID: 15552597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.